Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone

Severe COVID-19 infection in a kidney transplant recipient treated with lopinavir/ritonavir, hydroxychloroquine and dexamethasone

Severe COVID-19 infection management for a recipient of kidney transplant has debatable prognosis and treatment. We described the case of a COVID-19 infected 70 year old female, previously had renal transplantation in 2017. The patient took immunosuppressive agents as routine drugs for transplant r...

Full description

Saved in:
Bibliographic Details
Main Authors: Satriyo Dwi Suryantoro, Mochammad Thaha, Pranawa, Djoko Santoso, Nunuk Mardiana, Widodo, Aditiawardana, Artaria Tjempakasari, Ardityo Rahmat Ardhany, Dana Pramudya, Decsa Medika Hertanto, Evy Febriane, Meryana, Maria Angela, Ari Christy Muliono, Handoko Tanuwidjaja, Philia Setiawan, David Sugiarto
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2021-09-01
Series:Journal of Infection in Developing Countries
Subjects:
kidney transplant
immunosupressive drugs
lopinavir
ritonavir
hydroxycholorquine
Online Access:https://jidc.org/index.php/journal/article/view/14952
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/14952

Similar Items